FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $588,600 | -16.6% | 58,335 | +85.2% | 0.00% | -50.0% |
| Q3 2022 | $706,000 | +91.3% | 31,500 | +111.4% | 0.00% | +100.0% |
| Q2 2022 | $369,000 | -77.9% | 14,900 | -65.4% | 0.00% | -80.0% |
| Q1 2022 | $1,671,000 | +203.8% | 43,100 | +358.5% | 0.01% | +150.0% |
| Q4 2021 | $550,000 | +120.9% | 9,400 | +243.1% | 0.00% | +100.0% |
| Q4 2020 | $249,000 | +12350.0% | 2,740 | +149.1% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,100 | -15.4% | 0.00% | – |
| Q1 2016 | $2,000 | -94.3% | 1,300 | -87.4% | 0.00% | – |
| Q4 2015 | $35,000 | +25.0% | 10,300 | +94.3% | 0.00% | – |
| Q3 2015 | $28,000 | +460.0% | 5,300 | +657.1% | 0.00% | – |
| Q2 2015 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |